disopyramide has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 16 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Monomorphic sustained ventricular tachycardia (MSVT) was revisited in relation to the electrophysiologic findings and their relation to the drug efficacy." | 2.40 | Reentrant ventricular tachycardia. Interpretations of electrophysiologic findings and its applications. ( Aizawa, Y; Tanabe, Y; Yamaura, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (62.50) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Rowin, EJ | 1 |
| Sridharan, A | 1 |
| Madias, C | 1 |
| Firely, C | 1 |
| Koethe, B | 1 |
| Link, MS | 1 |
| Maron, MS | 1 |
| Maron, BJ | 1 |
| Perrin, T | 1 |
| Guieu, R | 1 |
| Koutbi, L | 1 |
| Franceschi, F | 1 |
| Hourdain, J | 1 |
| Brignole, M | 1 |
| Deharo, JC | 1 |
| Mizobuchi, M | 1 |
| Enjoji, Y | 1 |
| Yamamoto, R | 1 |
| Ono, T | 1 |
| Funatsu, A | 1 |
| Kambayashi, D | 1 |
| Kobayashi, T | 1 |
| Nakamura, S | 1 |
| Takada, Y | 1 |
| Isobe, S | 1 |
| Okada, M | 1 |
| Ando, A | 1 |
| Nonokawa, M | 1 |
| Inden, Y | 1 |
| Tomita, Y | 1 |
| Suzuki, A | 1 |
| Hirai, M | 1 |
| Murohara, T | 1 |
| Komori, S | 1 |
| Sano, S | 1 |
| Li, BH | 1 |
| Matsumura, K | 1 |
| Naitoh, A | 1 |
| Mochizuki, S | 1 |
| Ishihara, T | 1 |
| Watanabe, A | 1 |
| Umetani, K | 1 |
| Ijiri, H | 1 |
| Awaji, T | 1 |
| Hashimoto, K | 1 |
| Fiksinski, E | 1 |
| Martin, D | 1 |
| Venditti, F | 1 |
| Makkar, RR | 1 |
| Fromm, BS | 1 |
| Steinman, RT | 1 |
| Meissner, MD | 1 |
| Lehmann, MH | 1 |
| Ogawa, S | 2 |
| Mitamura, H | 2 |
| Katoh, H | 1 |
| Miyazaki, T | 1 |
| Miyoshi, S | 1 |
| Soejima, K | 1 |
| Aizawa, Y | 5 |
| Ebe, K | 1 |
| Shibata, A | 2 |
| Chinushi, M | 2 |
| Naitoh, N | 1 |
| Ogawa, Y | 1 |
| Shiba, M | 1 |
| Takahashi, K | 1 |
| Tanabe, Y | 1 |
| Yamaura, M | 1 |
| Watanabe, T | 1 |
| Yamaki, M | 1 |
| Tachibana, H | 1 |
| Yamauchi, S | 1 |
| Kubota, I | 1 |
| Tomoike, H | 1 |
| Granowitz, EV | 1 |
| Tabor, KJ | 1 |
| Kirchhoffer, JB | 1 |
3 reviews available for disopyramide and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramid | 1993 |
Reentrant ventricular tachycardia. Interpretations of electrophysiologic findings and its applications.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Electrocardiogra | 1998 |
Potentially fatal interaction between azithromycin and disopyramide.
Topics: Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Azithromycin; Cat-Scratch Disease; Disopyramid | 2000 |
2 trials available for disopyramide and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Effects of antiarrhythmic agents on left ventricular function during exercise in patients with chronic left ventricular dysfunction.
Topics: Aged; Anti-Asthmatic Agents; Chronic Disease; Disopyramide; Exercise; Exercise Test; Female; Heart V | 2004 |
Clinical characteristics and EPS-guided therapy in 142 cases of sustained ventricular tachycardia.
Topics: Aged; Anti-Arrhythmia Agents; Catheter Ablation; Combined Modality Therapy; Disopyramide; Electrophy | 1996 |
11 other studies available for disopyramide and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Ca | 2020 |
Theophylline as an adjunct to control malignant ventricular arrhythmia associated with early repolarization.
Topics: Anti-Arrhythmia Agents; Child; Defibrillators, Implantable; Disopyramide; Humans; Male; Quinidine; R | 2018 |
Nifekalant and disopyramide in a patient with short QT syndrome: evaluation of pharmacological effects and electrophysiological properties.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Body Surface Potential Mapping; Disopyramide; Humans; M | 2008 |
Effects of bidisomide (SC-40230), a new class I antiarrhythmic agent, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats; comparison with mexiletine and disopyramide.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Complexes, Premature; Coronary Disease; Dis | 1995 |
Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Blood Pressure; Coronary Vessels; Disopyramide; Dogs; Dr | 1993 |
Electrical proarrhythmia with procainamide: a new ICD-drug interaction.
Topics: Aged; Defibrillators, Implantable; Disopyramide; Humans; Male; Mexiletine; Procainamide; Tachycardia | 1994 |
Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias: comparison with conventional class I drugs.
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disease Models, Animal; Disopyrami | 1993 |
Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Disopyramide; Electrocardiography; Humans; | 1996 |
Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Administration S | 1996 |
Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Dose-Response Relationship, | 1997 |
Anisotropic effects of sodium channel blockers on the wavelength for ventricular excitation in dogs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Dogs; Electr | 2000 |